These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 27369)

  • 1. Long-term blood pressure control with pindolol given once daily.
    Frithz G; Danielson M; Henningsen N; Malmborg RO; Nordström-Ohrberg G; Schröder G
    Eur J Cardiol; 1978; 7(2-3):131-6. PubMed ID: 27369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of pindolol dosage in hypertension by automatic indirect BP monitoring.
    Sheps SG; Schirger A; Spiekerman RE; Harman TR; O'Brien PC; Kleven MK; Kremer-Simpson K
    Arch Intern Med; 1985 Jan; 145(1):54-7. PubMed ID: 3970647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of 'responders' to long-term pindolol therapy from phasic changes in cardiovascular function during acute intravenous administration in essential hypertension.
    Logan AG; Milne BJ; Colman JM
    Clin Invest Med; 1978; 1(3-4):147-52. PubMed ID: 42504
    [No Abstract]   [Full Text] [Related]  

  • 6. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P; Jacobsson KA; Agert G
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract]   [Full Text] [Related]  

  • 7. Twice-daily pindolol and alprenolol in essential hypertension of moderate severity.
    Hartikainen M; Heikkilä J
    Ann Clin Res; 1976 Apr; 8(2):85-92. PubMed ID: 779590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pindolol eye drops (Glauco-Visken) - half year's results in glaucoma therapy].
    Merté HJ; Stryz JR; Mertz M
    Klin Monbl Augenheilkd; 1984 Mar; 184(3):227-32. PubMed ID: 6374263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action of beta-adrenergic blocking drugs in hypertension.
    Prichard BN; Owens CW
    Clin Physiol Biochem; 1990; 8 Suppl 2():1-10. PubMed ID: 1982756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activity and number of lymphocyte beta adrenergic receptors after protracted treatment with mepindolol sulfate of patients with essential arterial hypertension].
    Fabris B; De Biasi F; Fischetti F; Leprini R; Castellano M; Carretta R
    G Clin Med; 1990 Nov; 71(11):639-44. PubMed ID: 1964919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined effect of doxazosin and pindolol on blood pressure control and lipid concentrations in patients with essential hypertension selected from general practice. Hunter Hypertension Research Group.
    J Hum Hypertens; 1992 Jun; 6(3):181-4. PubMed ID: 1352827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of pindolol given once daily in a dose of 15 mg in arterial hypertension].
    Barraine R; Bouchez C
    Nouv Presse Med; 1978 Sep; 7(31):2765-6. PubMed ID: 30959
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antihypertensive therapy with a new beta-blocking agent Timolol. Double blind study and comparison with Alprenolol and Pindolol (author's transl)].
    Wessels F; Heinze A; Werth HW
    Med Klin; 1977 Oct; 72(41):1689-95. PubMed ID: 335203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-Adrenoceptor blockers in the treatment of hypertension.
    Falase AO; Salako LA
    Afr J Med Med Sci; 1979; 8(1-2):13-8. PubMed ID: 45432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Single daily dose of pindolol in the treatment of arterial hypertension].
    Ciaramelli F
    Nouv Presse Med; 1978 Sep; 7(31):2761-4. PubMed ID: 30958
    [No Abstract]   [Full Text] [Related]  

  • 19. The significance of beta1-beta2-selectivity and intrinsic sympathomimetic activity in beta-blockers, with particular reference to antihypertensive treatment.
    Imhof P
    Adv Clin Pharmacol; 1976; 11():26-32. PubMed ID: 25568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of cold challenge on finger skin temperature during long-term use of beta-adrenoceptor blocking drugs in hypertensive patients.
    Wollersheim H; Lenders J; Peters H; Thien T
    Int Angiol; 1987; 6(3):307-11. PubMed ID: 2896221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.